Skip to main content

Year: 2019

Shineco, Inc. Announces the Completion of its First Board Meeting for Fiscal Year 2019

BEIJING, Dec. 06, 2019 (GLOBE NEWSWIRE) — Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, hemp products, and various health and well-being focused plant-based products in China, announced today that it completed its first board meeting (the “Meeting”) for fiscal year 2019 held on November 26, 2019 in Beijing, China and pursuant to which the Company’s directors:Re-elected Mr. Yuying Zhang as the Chairman of the Board of Company to hold office until the next annual general meeting.Elected Mr. Baolin Li as the Vice Chairman of the Board of Company to hold office until the next annual general meeting.Elected Mr. Harry Edelson as an independent director of the Board of Company.Mr. Harry Edelson has worked...

Continue reading

IES Holdings Reports Fiscal 2019 Fourth Quarter and Year-End Results

– Revenue of $1.1 billion for Fiscal 2019, an increase of 23% year-over-year– Fiscal 2019 Net Income Per Share of $1.55 and Adjusted Net Income Per Share of $1.79HOUSTON, Dec. 06, 2019 (GLOBE NEWSWIRE) — IES Holdings, Inc. (or “IES” or the “Company”) (NASDAQ: IESC) today announced financial results for the quarter and fiscal year ended September 30, 2019.Fourth Quarter and Fiscal Year 2019 HighlightsRevenue of $294 million for the fourth quarter of fiscal 2019, an increase of 22% compared with $240 million for the fourth quarter of fiscal 2018; Revenue of $1.1 billion for fiscal 2019, an increase of 23% compared with $877 million for fiscal 2018Operating income of $13.9 million for the fourth quarter of fiscal 2019, an increase of 59% compared with $8.7 million for the fourth quarter of fiscal 2018; Operating income...

Continue reading

Orgenesis and Theracell to Launch Point of Care Cell and Gene Therapy Centers within HYGEIA Group’s Hospital Network in Greece

GERMANTOWN, Md., Dec. 06, 2019 (GLOBE NEWSWIRE) — Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a leading cell and gene therapy enabling company providing centralized CDMO manufacturing and development services through its subsidiary Masthercell Global, Inc., as well as localized point-of-care (“POCare”) development and processing centers for therapeutic treatments, today announced a strategic partnership agreement (“Partnership”) between the HYGEIA Group and the Theracell–Orgenesis joint venture (“JV”).  Under the Agreement, the JV will implement Orgenesis’ POCare cell therapy platform for clinical development and commercialization of cell and gene therapies within HYGEIA Group’s network of three hospitals in Greece. As previously announced, Orgenesis and TheraCell Advanced Biotechnology formed a JV to advance Orgenesis’...

Continue reading

goeasy Ltd. Named a Top Employer in the Greater Toronto Area

MISSISSAUGA, Ontario, Dec. 06, 2019 (GLOBE NEWSWIRE) — goeasy Ltd. (TSX: GSY), a leading full-service provider of goods and alternative financial services, has announced it has earned a spot on the 2020 Greater Toronto Area (GTA) Top Employer list. goeasy has earned five awards in 2019 including recognition for its exceptional culture, continued business growth and its purpose to help everyday Canadians on a path to a better financial future. “We are honoured to be listed as a Top Employer within the Greater Toronto area,” said Jason Mullins, President and Chief Executive Officer, goeasy Ltd. “We continue to build and nurture our culture – where we cultivate opportunities for employees to do meaningful, purpose-driven work and where we reward strong values, innovation, diversity and performance. This award is particularly meaningful...

Continue reading

Viking Cylinders, a Hexagon Ragasco brand joins the Arbor Day Foundation’s Time for Trees™ Initiative

Viking Cylinders, a Hexagon Ragasco brand, today announced it is joining the Arbor Day Foundation for the launch of its Time for Trees initiative, a commitment to plant 100 million trees in forests and communities worldwide by 2022, alongside its partners.“Every time a consumer switches from a steel tank to a Viking Cylinder, we will plant a tree,” said Sean Ellen, Managing Director of Hexagon Ragasco North America.See attached press release by Hexagon Ragasco for more information.About Hexagon RagascoViking Cylinders is the North American brand of Hexagon Ragasco. Hexagon Ragasco is the world’s leading producer of composite LPG cylinders with over 16 million units in globally and over 100,000 in the US. The high-volume, highly automated production facility in Raufoss, Norway is the most advanced of its kind world-wide. Hexagon...

Continue reading

Conversion Labs Announces Official Launch of Men’s Telehealth Brand Rex MD

NEW YORK, Dec. 06, 2019 (GLOBE NEWSWIRE) — Conversion Labs, Inc. (CVLB) (“Conversion Labs” or “Company”), an e-commerce and telemedicine company focused on creating and scaling proprietary health and wellness brands, today announced its official launch of Rex MD, a male-oriented telemedicine brand.Customers can now visit www.rexmd.com where they can be diagnosed and prescribed prescription medications that are discretely delivered to their home.  Rex MD is initially focused on the treatment of erectile dysfunction and will offer additional prescription medications for men in the coming months.Due to trends such as rising internet proficiency, rising healthcare costs, and customer demand for convenience, the global telemedicine market is expected to reach $130 billion by 2025 according to Global Market Insights. Expected to grow at...

Continue reading

MediPharm Labs Australia Granted State Licences, Completes Construction of Specialized Production Facility

BARRIE, Ontario, Dec. 06, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation and purification, today announced that its subsidiary, MediPharm Labs Australia Pty. Ltd. (“MediPharm Labs Australia”), has received State Licences for cannabis substances from the Department of Health and Human Services in Victoria, Australia and completed the initial phases of construction of its specialized extraction facility in Wonthaggi.Under these State Licences, MediPharm Labs Australia is allowed to store, test and supply cannabis for research purposes at its newly built facility. Construction of the 10,000 square foot plant began 18 months ago. The final stage of regulatory approvals is now underway...

Continue reading

Post Holdings Announces New Share Repurchase Authorization of $400 Million

ST. LOUIS, Dec. 06, 2019 (GLOBE NEWSWIRE) — Post Holdings, Inc. (NYSE:POST), a consumer packaged goods holding company, today announced its Board of Directors has approved a new $400 million share repurchase authorization, with share repurchases under the new authorization beginning on December 6, 2019. As of December 5, 2019, Post had repurchased approximately $252 million under its previous $400 million stock repurchase authorization, which was approved on September 4, 2019 and was cancelled effective December 5, 2019.Repurchases may be made from time to time in the open market, in private purchases, through forward, derivative, accelerated repurchase or automatic purchase transactions, or otherwise. The shares would be repurchased with cash on hand and cash from operations. Any shares repurchased would be held as treasury stock....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.